The African population offers greater genomic diversity in comparison to any other people group in the world, according to Science. Despite this, most genetic research is conducted in European countries, raising concerns for the integrity of medical research. This is why Nigerian-based startup 54gene is combatting the discrepancies in genomic research through its health technologies. The advancements will provide medical discoveries for the African population and the diaspora. To date, the genomic startup founded by Dr. Abasi Ene-Obong has collected over 300,000 genomic samples. The companies efforts will expand its medical discoveries thanks to $25 million raised in a Series B funding round, a press release states. The round was led by capital firm Cathay AfricInvest Innovation Fund and included Plexo Capital, KdT Ventures, Ingressive Capital, Adjuvant Capital, Endeavor Capital and more. The company’s promising impact on the future of drug and health research is drawing in...